Tumark® Vision
The benchmark for ultrasound visibility
Visibility
Intelligent 3D design of the vision-marker provides very good visibility in ultrasound, X-ray and MRI
Stability
Marker expands into shape upon deployment and anchors firmly in the tissue
Single-handed operation
Ergonomic handle allows for single-handed use
Tumark® Vision
Spherical premium marker
With the Tumark Vision marker we have set new standards for the visibility of biopsy site markings in ultrasound. Due to its unique spherical shape and surface structure, the marker is highly visible in ultrasound – regardless of transducer positions. The three-dimensional design of the marker also allows a very good detection in other imaging procedures (mammography, CT, MRT).
- Very good visibility in ultrasound, X-ray and MRI [1]
- Long-term stability, particularly important in neoadjuvant chemotherapy (NACT)
- Marker made from long-term stable implant material Nitinol
- MRI version for MR controlled biopsy site marking up to 3 Tesla available: Tumark Vision MRI
- Simple handling
- 18 Gauge thin, sharp puncture cannula
- Ergonomic handle allows for single-handed use
[1] Tumark Vision site marker is MRI compatible. Tumark Vision application device is not suitable for use in MRI. For biopsy site marking in MRI, we recommend Tumark Vision MRI and Tumark MRI.
The videos were filmed in the breast center of Evang. Kliniken Essen-Mitte, in Essen, Germany and show the everyday clinical practice there.
Tumark® Vision in imaging methods
Tumark Vision in ultrasound, 3 months after marking with tumor findings not (no longer) clearly definable
Tumark Vision in ultrasound, 5 months after marking following completion of NACT (6xTCbHP) with tumor findings not (no longer) clearly definable
Mammographic imaging of Tumark Vision in breast tissue
Tumark Vision in ultrasound
Tumark® Vision Study*
Our products regularly prove themselves in independent studies. A study conducted by the clinics of Essen Mitte in Essen and the Charité in Berlin, Germany rates the clinical application of Tumark Vision as excellent. All 50 patients at the Essen Mitte Clinics were treated with the Tumark Vision biopsy site marker. 50 primary lesions as well as the lymph nodes of 23 patients were marked.
*Source: Rüland, A. M., Hagemann, F., Reinisch, M., Holtschmidt, J., Kuemmel, A., Dittmer-Grabowski, C., Stöblen F., Rotthaus H., Dreesmann V., Blohmer J.-U. Kuemmel, S. (2018). Using a New Marker Clip System in Breast Cancer: Tumark Vision Clip-Feasibility Testing in Everyday Clinical Practice. Breast Care, 13(2).
Visibility of Tumark® Vision on the day of application
- Very good 72%
- Good 24%
- Poor 4%
- 100% stability
In all cases, the marker remained firmly anchored in the tissue. - 100% visibility
In all cases, the marker could be identified under ultrasound. - 100% handling
In all cases, the application of the marker was unproblematic.
Tumark® Vision MRI
MRI version for MR controlled biopsy site marking
The Tumark Vision MRI is designed for MR biopsy site marking up to 3 Tesla. The compact design of the MR application system is particularly suitable for use in the MR gantry area.
Order information
Tumark® Vision
Product code 271589 / 18 Gauge / 1.20 mm diameter / 100 mm cannula length
Product code 271590 / 18 Gauge / 1.20 mm diameter / 120 mm cannula length
Tumark® Vision MRI
Product code 601590 / 18 Gauge / 1.20 mm diameter / 120 mm cannula length
Packing unit per product: 10 pieces, minimum order quantities may be required Shelf life from production date: 5 years
Tumark® Vision image gallery
Tumark Vision
Tumark Vision
Tumark Vision Marker
Tumark Vision MRI
Tumark® Vision Atlas
Case studies
The Tumark Vision Atlas contains case studies of the Tumark Vision biopsy site marker and provides clinical information. The long-term visibility of a biopsy site marker is particularly important in neoadjuvant chemotherapy. Some of the following case studies report this application scenario.
Instructions for use
Tumark Vision